High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

Journal of Experimental Medicine

Volumn 188, Issue 6, 1998, Pages 1203-1208

  Ogg, Graham S ^a   Dunbar, P Rod ^a   Romero, Pedro ^b   Chen, Ji Li ^a   Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Auto immunity; Cytotoxic T lymphocytes; Fluorescence activated cell sorter; Human; Skin

Indexed keywords

ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MELANOCYTE; PRIORITY JOURNAL; VITILIGO;

ALLELES; AUTOIMMUNE DISEASES; CELL LINE; CELL MOVEMENT; CYTOTOXICITY TESTS, IMMUNOLOGIC; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MELANOCYTES; MELANOMA; PEPTIDES; SKIN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VITILIGO;

EID: 0032555910     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.6.1203     Document Type: Article

References (28)

1. Song, Y.H., E. Connor, Y. Li, D. Zorovich, P. Balducci, and N. Maclaren. 1994. The role of tyrosinase in autoimmune vitiligo. Lancet. 344:1049-1052.
2. Kemp, E.H., D.J. Gawkrodger, P.F. Watson, and A.P. Weetman. 1997. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin. Exp. Immunol. 109:495-500.
3. Hara, I., Y. Takechi, and A.N. Houghton. 1995. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. 182:1609-1614.
4. Merimsky, O., Y. Shoenfeld, E. Baharav, M. Altomonte, S. Chaitchik, M. Maio, S. Ferrone, and P. Fishman. 1996. Melanoma-associated hypopigmentation: where are the antibodies? Am. J. Clin. Oncol. 19:613-618.
5. Naughton, G.K., M. Eisinger, and J.C. Bystryn. 1983. Antibodies to normal human melanocytes in vitiligo. J. Exp. Med. 158:246-251.
6. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
7. Coulie, P.G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.-P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
8. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. Robbins, L. Rivoltini, J. Yannelli, E. Appella, and S. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
9. Nordlund, J.J., J.M. Kirkwood, B.M. Forget, G. Milton, D.M. Albert, and A.B. Lerner. 1983. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J. Am. Acad. Dermatol. 9:689-696.
10. Duhra, P., and A. Ilchyshyn. 1991. Prolonged survival in metastatic malignant melanoma associated with vitiligo. Clin. Exp. Dermatol. 16:303-305.
11. Badri, A.M., P.M. Todd, J.J. Garioch, J.E. Gudgeon, D.G. Stewart, and R.B. Goudie. 1993. An immunohistological study of cutaneous lymphocytes in vitiligo. J. Pathol. 170:149-155.
12. Le Poole, L. R. van den Wijngaard, W. Westerhof, and P.K. Das. 1996. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Pathol. 148:1219-1228.
13. Fuhlbrigge, R.C., J.D. Kieffer, D. Armerding, and T.S. Kupper. 1997. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature. 389:978-981.
14. Borges, E., G. Pendl, R. Eytner, M. Steegmaier, O. Zollner, and D. Vestweber. 1997. The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated. J. Biol. Chem. 272:28786-28792.
15. Nestle, F.O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-332.
16. Erf, G.F., S.A. Trejo, and J.J. Smyth. 1995. T cells in regenerating feathers of Smyth line chickens with vitiligo. Clin. Imtnunol. Immunopathol. 76:120-126.
17. Altman, J.D., P. Moss, P. Goulder, D.H. Barouch, W.M. McHeyzer, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
18. Wolfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.H. Meyer zum Buschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759-764.
19. Cox, A., J. Skipper, Y. Chen, R. Henderson, T. Darrow, J. Shabanowitz, V. Engelhard, D. Hunt, and C. Slingluff. 1994. Identification of a peptide recognized by five melanoma-spe-cific human cytotoxic T cell lines. Science. 264:716-719.
20. Skipper, J.C., R.C. Hendrickson, P.H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wolfel, C.L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527-534.
21. Valmori, D., J.F. Fonteneau, C.M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J.C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160:1750-1758.
22. Parker, K.C., M.A. Bednarek, L.K. Hull, U. Utz, B. Cunningham, H.J. Zweerink, W.E. Biddison, and J.E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149: 3580-3587.
23. Lalvani, A., T. Dong, G. Ogg, A.A. Patham, H. Newell, A.V. Hill, A.J. McMichael, and J.S. Rowland. 1997. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods. 210:65-77.
24. Ogg, G.S., X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A. Nowak, S. Monard, J.P. Segal, Y. Cao, J.S. Rowland, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:2103-2106.
25. Murali, K.K., J.D. Altman, M. Suresh, H.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187.
26. Dunbar, P.R., G.S. Ogg, J. Chen, N. Rust, P. van der Bruggen, and V. Cerundolo. 1998. Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood. Curr. Biol. 8:413-416.
27. Visseren, M., A. van Elsas, E. van der Voort, M. Ressing, M. Kast, P. Schrier, and C. Melief. 1995. CTL specific for the tyrosinase can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154:3991-3998.
28. van Elsas, A., S. van der Burg, C. van der Minne, M. Borghi, J.S. Mourer, C.J. Melief, and P.I. Schrier. 1996. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A(Black star)0201-binding peptides from the Melan-A/MART-1 self antigen. Eur. J. Immunol. 26:1683-1689.